Xcout Intel
Enorama Pharma
Enorama Pharma is a Swedish pharmaceutical company that develops and commercializes consumer-friendly oral nicotine products, specifically focusing on tobacco-free white snus. The company markets its products under its proprietary NIC-S brand and through private labels, with a primary focus on the U.S. market.
Subscribe to see Enorama Pharma’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Enorama Pharma at a glance
Enorama Pharma is a health care company headquartered in Sweden. Xcout tracks 9 named people at Enorama Pharma, including Bengt Jönsson (Interim CEO and board member).
Enorama Pharma leadership
- Bengt JönssonInterim CEO and board member
- Jonas BrislandCFO
- Ara AbrahamianChairman of the board
- Fredrik OlssonBoard member
- Mikael ÅbomBoard member
- Rajesh KumarBoard member
3 more named people on record for Enorama Pharma, with roles, board committees and tenure — see the full roster →
Enorama Pharma competitors
A few of Enorama Pharma's closest competitors — see the full list of competitors and alternatives →
Enzymatica develops health solutions and barrier technology products, such as the ColdZyme mouth spray, designed to support the body's defense against viruses and micro-organisms. The company serves consumers looking to prevent or alleviate common cold symptoms and respiratory infections.
Initiator Pharma is a clinical-stage biotechnology company that develops therapeutics targeting monoamine neurotransmitters for conditions such as erectile dysfunction, vulvodynia, and female sexual dysfunction. The company advances a pipeline of clinical and preclinical drug candidates, including its lead asset pudafensine, to address unmet medical needs in sexual medicine.
Stenocare is a publicly traded pharmaceutical company that innovates, imports, and distributes prescription-based medical cannabis products. The company serves patients and healthcare providers in Northern Europe and Australia by supplying regulated, pharmaceutical-grade cannabis treatments for pain and various other conditions.
Newbury Pharmaceuticals is a hybrid pharmaceutical company operating primarily in the Nordic region that commercializes and distributes a diverse portfolio of medicines. The company acts as a marketing authorization holder and exclusive local representative for international partners, providing high-quality pharmaceutical products across multiple therapeutic areas.
NextCell Pharma is a Swedish biotechnology company that develops advanced stem cell therapies, focusing primarily on treatments for autoimmune and inflammatory diseases such as type 1 diabetes with its drug candidate ProTrans. The company also operates Cellaviva, which is Scandinavia's largest stem cell bank.
Salipro Biotech AB is a privately held biotechnology company headquartered in Stockholm, Sweden. The company is focused on unlocking challenging drug targets to advance drug discovery and develop next-generation therapeutics.
Get Enorama Pharma's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Enorama Pharma? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Enorama Pharma in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access